It does not demonstrate clinical efficacy, comprehensive safety, sterility, endotoxin control, or regulatory approval unless those attributes were specifically tested under suitable validated methods and the relevant regulatory requirements were met
GLP-1R activation is associated with reduced appetite signalling and improved insulin secretion
Barriers and facilitators to starting insulin in patients with type 2 diabetes: a systematic review
Insert the needle straight into the skin
Side effects : Common : Nausea, diarrhea, upper respiratory infection, headache, low blood sugar Serious : Severe hypoglycemia, pancreatitis, kidney problems, severe allergic reactions Important warnings : Can cause dangerous low blood sugar especially when combined with sulfonylureas